Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli)

  • Favorite

Product Information

  • Dosage Form:Injection
  • Route of Administration:Intramuscular Injection
  • Shelf Life:3 years
  • Storage:2℃-8℃
  • Qualification:WHO PQ

Description



Target Countries:

Central& South America, Southeast Asia

   

Highlights: 

1. Exclusive vaccine to prevent the most common female malignant tumor - Cervical Cancer;

2. Prevent 84.5% of cervical cancer;

3. Target for female aged 9-46 yrs;

4. WHO PQ approved;

5. More affordable price than 4-valent/9-valent HPV vaccine.


Expression System:

Escherichia coli


Formulation:

With Alum adjuvant. No preservative


Target population:

Women ages 9-45years


Schedule:

0, 1, 6 m (0, 6m for 9 -14 yrs) 


Shelf-life:

2-8℃ 36 months in application


Specific Requirements:

Deal in the related industry;
Familiar with local regulation for drug entry;
Familiar with local sales channel and market;
Active and confident in promoting the product.


Shenzhen Mellow Hope Pharm Industrial co.,Ltd.

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

8/10
You Might Also Like
Change a group
Inquiry Cart(0)